🔓 Unlock the full profile of Tania Dimitrova (Artios), including verified contact details, financial insights, and professional associations.
See Tania Dimitrova Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: tan*****@art******.com
Mobile: 76394*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Tania Dimitrova is the Co-founder and Chief Financial Officer at Belenos Biosciences, contributing to the financial and strategic direction of the organization since July 2024.
- As a Board Member at Roshon Therapeutics since November 2024, Tania brings a wealth of experience in guiding and supporting new therapeutic developments.
- Previously served as Chief Business Officer at Artios Pharma Ltd from May 2019 to January 2024, overseeing critical business strategies and partnerships that facilitated growth.
- At Pfizer, held the position of Director of Transactions within the Innovative Health, Worldwide Business Development division from July 2014 to May 2019, leading major transactions and initiatives that enhanced the company's market position.
- Contributed to business development efforts as Associate Director in the Mergers & Acquisitions Group at Bristol-Myers Squibb from September 2012 to July 2014, focusing on strategic acquisitions and partnerships.
- Instrumental in establishing practices and procedures that supported financial stability and strategic growth phases for various organizations.
- Has been a part of innovative biotechnology and pharmaceutical companies, emphasizing the importance of developing sustainable business models in the healthcare sector.
- Under Tania's financial stewardship, Artios Pharma has seen significant developments in its operational strategies and market outreach, aligning with industry trends and demands.